Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Earnings Winners And Losers: BSX, CYNO, EW, GB, STJ, BCR, EXAC

This article was originally published in Clinica

Executive Summary

Boston Scientific (BSX), Cynosure (CYNO), and Edwards (EW) are among the companies reporting their first quarter sales and earnings. Here are a few highlights (and lowlights) from those reports.

You may also be interested in...



Earnings Winners and Losers: BSX, EW, ABT, JNJ, SYK, ZBH

Many medtech companies reported their sales and earnings for all of 2016, along with projections for 2017, at the end of January or early February. Medtech Insight has examined their reports as well as the comments of the analysts who track these companies to highlight a few that had especially good years, some that had down years, and some lesser-known companies worth watching in the future.

MRI Labeling For Boston Scientific's Emblem MRI S-ICD Approved By US FDA

Boston Scientific cardiac rhythm management has been struggling to compete with MRI-compatible devices from rival Medtronic.

Earnings Winners And Losers: ABT, ISRG, STJ, SYK

Here are some of the highlights (and lowlights) from the second-quarter sales and earnings reports that medical device companies announced last week.

Topics

Latest News
UsernamePublicRestriction

Register

MT103391

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel